SCHEMBL3419014

SCHEMBL3419014

CCN(CC)C(=O)c1nc(-c2cccnc2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.52
RAB9A P51151 7/20 0.52
SMN1; SMN2 Q16637 7/20 0.52
TP53 P04637 5/20 0.52
MAPT P10636 4/20 0.52
LMNA P02545 1/20 0.52
KMT2A Q03164 1/20 0.52
CHRNB2 P17787 1/20 0.51
CHRNA5 P30532 1/20 0.51
CHRNA4 P43681 1/20 0.51
PPARA Q07869 3/20 0.50
PKM P14618 1/20 0.49
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
ALDH1A1 P00352 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KDM4E B2RXH2 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27768478 0.81 CHRNB2 (0.63) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL7659667 0.80 HTT (0.60) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL1815822 0.79 CHRNB2 (0.61) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL3418996 0.77 GAA (0.57) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL1432036 0.77 MKNK1 (0.57) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL14427066 0.74 NPC1 (0.47) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL3414735 0.74 CYP2A6 (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
Nikethamide SCHEMBL246456 0.73 HTT (0.65) SMN1; SMN2MAPTLMNAALDH1A1NPSR1
Nikethamide SCHEMBL29754232 0.73 HTT (0.65) SMN1; SMN2MAPTLMNAALDH1A1NPSR1
SCHEMBL12369729 0.72 PPARA (0.72) NPC1RAB9ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593447-B1 3-PYRIDYL-HETEROARYLCARBOXAMIDE COMPOUNDS AS PESTICIDES BAYER IP GMBH (DE) 2016-08-17 EP disclosed
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides BAYER CROP SCIENCE AG (DE) 2012-04-19 US disclosed
WO-2012007500-A2 NEW HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides DDT, PTMS, ACHE NPC1 4000/4885RAB9A 717/4885SMN1; SMN2 3305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.